P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2

被引:59
作者
Chen, Lei [1 ,2 ,3 ]
Zhang, Run [1 ,2 ,3 ]
Li, Peng [1 ,2 ,3 ]
Liu, Yi [1 ,2 ,3 ]
Qin, Kun [1 ,2 ,3 ]
Fa, Zhi-qiang [1 ,2 ,3 ]
Liu, Yi-jing [1 ,2 ,3 ]
Ke, Yi-quan [1 ,2 ,3 ]
Jiang, Xiao-dan [1 ,2 ,3 ]
机构
[1] Southern Med Univ, Dept Neurosurg, Zhujiang Hosp, Guangzhou 510282, Guangdong, Peoples R China
[2] Southern Med Univ, Natl Key Clin Specialty, Guangzhou 510282, Guangdong, Peoples R China
[3] Southern Med Univ, Neurosurg Inst Guangdong Prov, Guangdong Prov Key Lab Brain Funct Repair & Regen, Guangzhou 510282, Guangdong, Peoples R China
关键词
Glioma; P53; miR-107; CDK6; Notch-2; MALIGNANT GLIOMAS; CANCER; GLIOBLASTOMA; TEMOZOLOMIDE; TARGETS; MIR-107; GENES; WORLD; LINES; P53;
D O I
10.1016/j.neulet.2012.11.047
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
MicroRNAs (miRNAs) are small noncoding RNAs that function as tumor suppressors or oncogenes. MicroRNA-107 (miR-107), a transcriptional target of p53, is deregulated in many cancer cell lines. Here, we showed that miR-107 is down-regulated in glioma tissues and cell lines, in particular, p53-mutated U251 and A172. Transfection of wild-type p53 into these cells stimulated miR-107 expression. To investigate the role of miR-107 in tumorigenesis, we constructed a lentiviral vector overexpressing miR-107. Notably, miR-107 inhibited proliferation and arrested the cell cycle at the G0-G1 phase in glioma cells. Transduction of Lenti-GFP-miR-107 into glioma cells inhibited CDK6 and Notch-2 protein expression. Our findings collectively demonstrate that p53-induced miR-107 suppresses brain tumor cell growth and down-regulates CDK6 and Notch-2 expression, supporting its tumor suppressor role and utility as a target for glioma therapy. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:327 / 332
页数:6
相关论文
共 32 条
[1]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[2]   The Tumor Suppressors p53, p63, and p73 Are Regulators of MicroRNA Processing Complex [J].
Boominathan, Lakshmanane .
PLOS ONE, 2010, 5 (05)
[3]   Changes in circulating microRNA levels associated with prostate cancer [J].
Bryant, R. J. ;
Pawlowski, T. ;
Catto, J. W. F. ;
Marsden, G. ;
Vessella, R. L. ;
Rhees, B. ;
Kuslich, C. ;
Visakorpi, T. ;
Hamdy, F. C. .
BRITISH JOURNAL OF CANCER, 2012, 106 (04) :768-774
[4]  
Büschges R, 1999, BRAIN PATHOL, V9, P435
[5]  
Chen Jie, 2010, Genes Cancer, V1, P822, DOI 10.1177/1947601910383564
[6]   MicroRNA-21 knockdown disrupts glioma growth In vivo and displays synergistic cytotoxicity with neural precursor cell-delivered S-TRAIL in human gliomas [J].
Corsten, Maarten F. ;
Miranda, Rafael ;
Kasmieh, Randa ;
Krichevsky, Anna M. ;
Weissleder, Ralph ;
Shah, Khalid .
CANCER RESEARCH, 2007, 67 (19) :8994-9000
[7]   Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation [J].
Cui, J. G. ;
Zhao, Y. ;
Sethi, P. ;
Li, Y. Y. ;
Mahta, A. ;
Culicchia, F. ;
Lukiw, W. J. .
JOURNAL OF NEURO-ONCOLOGY, 2010, 98 (03) :297-304
[8]   microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cε [J].
Datta, J. ;
Smith, A. ;
Lang, J. C. ;
Islam, M. ;
Dutt, D. ;
Teknos, T. N. ;
Pan, Q. .
ONCOGENE, 2012, 31 (36) :4045-4053
[9]   miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells [J].
Feng, Li ;
Xie, Yun ;
Zhang, Hao ;
Wu, Yunlin .
MEDICAL ONCOLOGY, 2012, 29 (02) :856-863
[10]   Malignant astrocytic glioma: genetics, biology, and paths to treatment [J].
Furnari, Frank B. ;
Fenton, Tim ;
Bachoo, Robert M. ;
Mukasa, Akitake ;
Stommel, Jayne M. ;
Stegh, Alexander ;
Hahn, William C. ;
Ligon, Keith L. ;
Louis, David N. ;
Brennan, Cameron ;
Chin, Lynda ;
DePinho, Ronald A. ;
Cavenee, Webster K. .
GENES & DEVELOPMENT, 2007, 21 (21) :2683-2710